JPMorgan analyst Robbie Marcus raised the firm’s price target on Penumbra (PEN) to $275 from $265 and keeps a Neutral rating on the shares. The company reported a “beat and raise” quarter amid stroke market challenges, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEN:
- Penumbra’s Strong Financial Performance and Strategic Advancements Reinforce Buy Rating
- Buy Rating for Penumbra: Strong Q3 Performance and Future Growth Catalysts
- Penumbra, Inc. Reports Strong Q3 2025 Growth
- Closing Bell Movers: Qualcomm down 3%, Robinhood slips 2% on earnings
- Penumbra reports Q3 non-GAAP EPS 97c, consensus 92c